IP Verse

Use Of Salts Of The Janus Kinase Inhibitor (R)-3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H- Pyrazol-1-Yl)-3- Cyclopentylpropanenitrile

PatentPatent Analysis

EP3070090

INCYTE
Application Number
EP16152794A
Filing Date
Jun 12, 2008
Status
Revoked
Nov 26, 2021
Grant Date
Dec 12, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3773593B1
EP2919766B1
EP3184526B1

Bibliography

The patent EP3070090B1 was granted to Incyte on Dec 12, 2018 following the initial filing on Jun 12, 2008 under the application number EP16152794A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKSep 6, 2019ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents